Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds
暂无分享,去创建一个
H. DeLuca | S. Marx | H. Goto | J. Prahl | R. Wiese | Monique Thomas | A. Al-aqeel
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] I. Yokota,et al. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. , 1991, American journal of human genetics.
[3] H. DeLuca,et al. Sites of phosphorylation and photoaffinity labeling of the 1,25-dihydroxyvitamin D3 receptor. , 1991, Archives of biochemistry and biophysics.
[4] Z. Hochberg,et al. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. , 1990, The Journal of clinical investigation.
[5] U. Liberman,et al. A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1,25-dihydroxyvitamin D3. , 1990, Molecular endocrinology.
[6] H. DeLuca. Mechanism of action of 1,25-dihydroxyvitamin D3: 1990 version , 1990 .
[7] J. Shine,et al. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. , 1989, Science.
[8] H. DeLuca,et al. An immunoradiometric assay for 1,25-dihydroxyvitamin D3 receptor. , 1989, Analytical biochemistry.
[9] U. Liberman,et al. Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. , 1989, The Journal of clinical investigation.
[10] B. O’Malley,et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. , 1988, Science.
[11] H. DeLuca. The vitamin D story: a collaborative effort of basic science and clinical medicine 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] M. Brandi,et al. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. , 1988, The Journal of clinical endocrinology and metabolism.
[13] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[14] H. DeLuca,et al. Direct chemical synthesis of 1 alpha,25-dihydroxy[26,27-3H]vitamin D3 with high specific activity: its use in receptor studies. , 1980, Biochemistry.
[15] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[16] A. Norman,et al. An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. , 1979, Analytical biochemistry.
[17] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[18] J. Pike,et al. Vitamin D3 receptors: structure and function in transcription. , 1991, Annual review of nutrition.
[19] N. Vermeulen,et al. Comprehensive medicinal chemistry , 1991 .
[20] K. Yamamoto,et al. Steroid receptor regulated transcription of specific genes and gene networks. , 1985, Annual review of genetics.
[21] U. Liberman,et al. Hereditary resistance to 1,25-dihydroxyvitamin D. , 1984, Recent progress in hormone research.